News Center
News Center
Industry News
[2026/09/29] : Veterinary API Regulation: China Tightens Oversight as Global Standards Move Toward Greater Harmonization[2026/09/27] : From APIs to Intermediates: China’s Veterinary API Industry Is Moving Toward Supply Chain Integration[2026/09/25] : Changing Demand from Large-Scale Farming Is Reshaping China’s Veterinary API Industry[2026/09/23] : Revenue Growth Without Profit Growth: How Capacity Expansion and Higher Regulatory Requirements Are Reshaping China’s Veterinary API Industry[2026/09/21] : China Strengthens Veterinary Drug Regulation to Curb Low-End Capacity and Promote High-Quality Industry Development[2026/09/19] : Technology Is Reshaping the Veterinary API Industry: From Conventional Manufacturing to Biomanufacturing and Intelligent Production[2026/09/17] : From Capacity Competition to Value Competition: China’s Veterinary API Industry Enters a New Cycle[2026/09/15] : Low-End Overcapacity, High-End Shortages: China’s Veterinary API Industry Is Rapidly Differentiating[2026/09/13] : High Oil Prices, Diverging Demand: What Is Happening in the Veterinary API Market in 2026?[2026/09/11] : Thailand and Vietnam Issue New Veterinary Drug Management Notifications[2026/09/09] : China’s Veterinary Pharmaceutical Industry Is Undergoing a Major Transformation[2026/09/07] : Four Key Mechanisms of Traditional Chinese Veterinary Medicine in Antibiotic Reduction[2026/09/05] : Micro-reactor Technology Reconstructs the Entire Antibiotic Production Process[2026/09/03] : The Most Unusual Chemical Raw Material Market Trend of 2026 Is Unfolding[2026/09/01] : Hainan Haiyao 2026 H1 Report: API Business Grows, but Profitability Remains Under Pressure[2026/08/30] : “15th Five-Year Plan” Veterinary Education High-Quality Development Seminar Held in Qingdao, Shandong[2026/08/28] : Antibiotic Intermediate Price Cuts: How KuanNing Biology Is Responding to a 39% Profit Decline with a 98% Surge in Cash Flow[2026/08/26] : CCTV Exposes: Multiple regions are conducting investigations to crack down on the illegal sale and misuse of prescription drugs.[2026/08/24] : New Insights into Tylvalosin Tartrate Against PRRSV: Study Reveals a TLR4/NF-κB-Mediated Pyroptosis Mechanism[2026/08/20] : Neomycin Sulfate Prices Continue to Decline: Market Trends from 2024 to 2026 and Outlook for H2 2026
| Enter Zhuocheng | Product | Honorary Qualifications | Contact Us |
| Company IntroductionFactory Appearance | Raw materials Premixed agent product OEM products |
Company：Jinan Zhuocheng Bio-Tech Co., Ltd. Corporate email：info@zhuochengbio.com Address:Building 3, Ligao International, 1222 West Aoti Road, Lixia District, Jinan |
